Nephrocare Health Services Ltd. Share Price

Daily Index View : SENSEX as on 19/08/2026

1. Market Trend PROBABILITY 🚨 Current Market Trend: Positive 🚀 -10% 🔍 Key Level to Watch: 77857 🔄 Current Market Surface: The trend will stay Positive until the market stay above 77857 That’s 622 points away from the last day Closing Price of 77235 ATR 700 2. Demand & Supply PROBABILITY Force is Demand & Supply is High -15% Last 3 days market has been flatish on downside compared to ATR, so supply has very strong firepower — it just needs sentiment support 18 Aug 2026 FII Cash-net (Buy/sell) DII Cash- net (BUY/SELL) +1,651.53 +2,579.31 3. Reflexivity PROBABILITY First Half is Mildly Supportive to Bearish Momentum for at least first half -5% Last day market fell Intraday around 25–50% of the 8-day average ATR, so downside momentum should remain intact in the first half 4. Social Proof (Global) PROBABILITY Dow Jones (Last day close) 48185 Up/Donw by -11 3% Dow jones future (live) 53,411 Up/Donw by +8.0 Hang seng (Live) 25471 Up/Donw by 28 Nikki 225 (Live) 65326 Up/Donw by -2,134 Sentiments: Dow Jones Futures is Trading Flat to Positive & HANG SENG Index is trading Flat to Positive Today, global markets are neutral to slightly positive, and the Indian market has no strong directional bias Top stock to watchout

Stock Story: NEPHROPLUS Exposed! The Secret to Its Resilience Revealed!

NephroPlus (Nephrocare Health Services) – The Recovery Play Current Status: Since its IPO in December 2025 (Issue Price: ₹460), it has been a star performer. It is currently trading near ₹577, having just reported stellar Q3 results (Revenue up 31% YoY). View: Strong Buy on Dips. The Scalp Strategy: It is currently consolidating after a post-earnings rally. It’s a very "clean" mover with less operator noise than Prime Focus. Entry: ₹575–₹580. Target (for the Hit): ₹590 (2% gain). Stop Loss: ₹565. RA Insight: Analysts have a consensus target of ₹615. It’s safer than KPIT because healthcare is currently a "defensive" sector where money is hiding while IT remains volatile.

Undervalued Stocks Near 52-Week Highs📈 Value + momentum = powerful combo🔖 These stocks are trading close to their highs, yet valuations are still reasonable — a sign of strong underlying demand 👀 Key names on the radar 👇 * Vedanta * ICICI Prudential AMC * Indus Towers * Ashok Leyland * Bank of India * NALCO * Sundaram Finance * Aether Industries * Lumax Industries * Nephrocare Health Services * Algoquant Fintech * Sacheerome * Divine Hira Jewellers * Ashwini Container Movers * AuSom Enterprise

Nephrocare Health IPO

Looking at Nephrocare Health's upcoming IPO, it strikes me as a fundamentally sound, high-growth dialysis chain with a compelling long-term trajectory, though immediate listing excitement might be tempered. This specialized player operates through a smart mix of company-owned, hospital-integrated, and government partnership centers, establishing a strong presence both in India and internationally. While IPO proceeds will wisely fuel expansion and debt reduction, the significant stake sale by existing promoters is a noteworthy point. On the financial front, growth has been impressive, with revenues almost doubling and profits stabilizing. Debt repayment should further bolster the bottom line, despite some visible working capital pressures. Valuation-wise, a P/E multiple around 75-80 times projected earnings feels rich, heavily leaning on future growth. However, its price-to-book multiple appears more aligned with some established hospital peers, even considering the distinct business models. My take? Nephrocare presents a compelling long-term narrative as a specialized, growing healthcare provider. However, the high valuation suggests short-term gains are likely moderate and uncertain. Investors might find better entry points after any initial market volatility, making it a patient accumulation play, not a quick flip.